Segui
Elisa Gabanti
Elisa Gabanti
Irccs Fondazione Policlinico San Matteo di Pavia
Email verificata su smatteo.pv.it
Titolo
Citata da
Citata da
Anno
9p21 locus analysis in high‐risk gastrointestinal stromal tumors characterized for c‐kit and platelet‐derived growth factor receptor α gene alterations
F Perrone, E Tamborini, GP Dagrada, F Colombo, L Bonadiman, ...
Cancer 104 (1), 159-169, 2005
742005
Neutrophil extracellular traps induce the epithelial-mesenchymal transition: implications in post-COVID-19 fibrosis
L Pandolfi, S Bozzini, V Frangipane, E Percivalle, A De Luigi, MB Violatto, ...
Frontiers in immunology 12, 663303, 2021
562021
PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcoma
MS Lagonigro, E Tamborini, T Negri, S Staurengo, GP Dagrada, F Miselli, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
542006
PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcoma
MS Lagonigro, E Tamborini, T Negri, S Staurengo, GP Dagrada, F Miselli, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
542006
Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients
E Gabanti, F Bruno, D Lilleri, C Fornara, P Zelini, I Cane, C Migotto, ...
PLoS One 9 (8), e106044, 2014
502014
Reconstitution of Human Cytomegalovirus–Specific CD4+ T Cells is critical for control of virus reactivation in hematopoietic stem cell transplant recipients but does not …
E Gabanti, D Lilleri, F Ripamonti, F Bruno, P Zelini, M Furione, ...
Biology of Blood and Marrow Transplantation 21 (12), 2192-2202, 2015
482015
Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors
T Rampino, M Gregorini, G Bedino, G Piotti, E Gabanti, A Ibatici, ...
Clinical science 120 (1), 25-36, 2011
422011
Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host
G Gerna, D Lilleri, C Fornara, F Bruno, E Gabanti, I Cane, M Furione, ...
Journal of General Virology 96 (2), 360-369, 2015
342015
KIT/Val654Ala receptor detected in one imatinib-resistant GIST patient
E Tamborini, E Gabanti, MS Lagonigro, T Negri, S Pilotti, MA Pierotti, ...
Cancer research 65 (3), 1115-1115, 2005
342005
Increased Erythrocyte Glutathione Peroxidase Activity and Serum Tumor Necrosis Factor-α in HIV-Infected Patients: Relationship to On-Going Prothrombotic State
R Trotti, M Rondanelli, A Anesi, E Gabanti, R Brustia, L Minoli
Journal of Hematotherapy & Stem Cell Research 11 (2), 369-375, 2002
262002
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
I Cassaniti, F Bergami, E Percivalle, E Gabanti, JC Sammartino, A Ferrari, ...
Clinical Microbiology and Infection 28 (2), 301. e1-301. e8, 2022
252022
Human cytomegalovirus-specific T-cell reconstitution and late-onset cytomegalovirus infection in hematopoietic stem cell transplantation recipients following letermovir prophylaxis
E Gabanti, O Borsani, AA Colombo, F Zavaglio, L Binaschi, D Caldera, ...
Transplantation and Cellular Therapy 28 (4), 211. e1-211. e9, 2022
242022
Human cytomegalovirus (HCMV)‐specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection …
D Lilleri, P Zelini, C Fornara, F Zavaglio, T Rampino, L Perez, E Gabanti, ...
Journal of medical virology 90 (10), 1620-1628, 2018
212018
Mechanisms underlying sCD40 production in hemodialysis patients
P Esposito, T Rampino, M Gregorini, E Gabanti, S Bianzina, A Dal Canton
Cellular immunology 278 (1-2), 10-15, 2012
212012
Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis
C Cereda, E Gabanti, M Corato, A De Silvestri, D Alimonti, E Cova, ...
Amyotrophic Lateral Sclerosis 7 (4), 233-240, 2006
202006
Analysis of the SARS-CoV-2 epidemic in Italy: The role of local and interventional factors in the control of the epidemic
D Lilleri, F Zavaglio, E Gabanti, G Gerna, E Arbustini
PLoS One 15 (11), e0242305, 2020
152020
Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients
D Lilleri, G Gerna, F Bruno, P Draghi, E Gabanti, C Fornara, F Meloni
New Microbiol 36 (3), 267-277, 2013
142013
Robust and persistent B-and T-cell responses after COVID-19 in immunocompetent and solid organ transplant recipient patients
F Zavaglio, V Frangipane, M Morosini, E Gabanti, P Zelini, JC Sammartino, ...
Viruses 13 (11), 2261, 2021
122021
Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients
E Gabanti, D Lilleri, L Scaramuzzi, P Zelini, T Rampino, G Gerna
New Microbiol 41 (3), 195-202, 2018
122018
CD40/SCD40 imbalance in hemodialysis patients
P Esposito, E Gabanti, S Bianzina, T Rampino, A Dal Canton
Clinical biochemistry 44 (2-3), 268-269, 2011
122011
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20